Healthy Extracts (HYEX) Accounts Payables (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Accounts Payables came in at $108496.0 in Q4 2025, up 107.66% year-on-year from $52248.0 in Q4 2024, and down 10.59% quarter-over-quarter from $121350.0 in Q3 2025.
Healthy Extracts (HYEX) Accounts Payables (2015 - 2025) Analysis & Trends
Healthy Extracts' Accounts Payables history runs 11 years deep, the most recent figure standing at $108496.0 for Q4 2025.
- On a quarterly basis, Accounts Payables rose 107.66% year-over-year to $108496.0 in Q4 2025; TTM through Dec 2025 was $108496.0, a 107.66% increase from a year earlier, with the FY2025 full-year figure at $108496.0, up 107.66% from the prior year.
- Accounts Payables declined to $108496.0 in Q4 2025 per HYEX's latest filing, from $121350.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $121350.0 in Q3 2025 and bottomed at $14722.0 in Q2 2021.
- The 5-year median for Accounts Payables is $98368.0 (2022), against an average of $82692.4.
- Across the five-year window, Accounts Payables slumped 66.74% in 2021 and surged 675.31% in 2022, its largest moves.
- Year by year, Accounts Payables stood at $37267.0 in 2021, then surged by 145.03% to $91316.0 in 2022, then rose by 27.95% to $116842.0 in 2023, then tumbled by 55.28% to $52248.0 in 2024, then surged by 107.66% to $108496.0 in 2025.
- Per Business Quant, the three latest HYEX Accounts Payables figures stand at $108496.0 (Q4 2025), $121350.0 (Q3 2025), and $114888.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 498.30 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | 731,000.00 |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 108,496.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 108,496.00 |
| Sep 30, 2025 | 121,350.00 |
| Jun 30, 2025 | 114,888.00 |
| Mar 31, 2025 | 80,919.00 |
| Dec 31, 2024 | 52,248.00 |
| Sep 30, 2024 | 42,703.00 |
| Jun 30, 2024 | 54,020.00 |
| Mar 31, 2024 | 117,515.00 |
| Dec 31, 2023 | 116,842.00 |
| Sep 30, 2023 | 68,537.00 |
| Jun 30, 2023 | 112,326.00 |
| Mar 31, 2023 | 114,485.00 |
| Dec 31, 2022 | 91,316.00 |
| Sep 30, 2022 | 114,066.00 |
| Jun 30, 2022 | 114,141.00 |
| Mar 31, 2022 | 105,420.00 |
| Dec 31, 2021 | 37,267.00 |
| Sep 30, 2021 | 23,158.00 |
| Jun 30, 2021 | 14,722.00 |
| Mar 31, 2021 | 49,430.00 |